Asthma: prevalence, pathogenesis, and prospects for novel therapies.
Woodruff
P G
PG
University of California, San Francisco, 505 Parnassus Ave, Box 0111, San Francisco, CA 94143, USA.
Fahy
J V
JV
D000486:Allergy and Immunology / Q000639:trends*; D000911:Antibodies, Monoclonal; D001249:Asthma / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D004781:Environmental Exposure; D006801:Humans; D007167:Immunotherapy; D007239:Infections; D016753:Interleukin-10; D018664:Interleukin-12; D015847:Interleukin-4 / Q000037:antagonists & inhibitors; D015848:Interleukin-5 / Q000037:antagonists & inhibitors; D015995:Prevalence; D018417:Th1 Cells; D018418:Th2 Cells
D000911:Antibodies, Monoclonal; D015848:Interleukin-5; C401983:rhuMAb-E25; D016753:Interleukin-10; D018664:Interleukin-12; D015847:Interleukin-4